| Total number of patients (N = 2399) | No surgery (N = 1511) | Received surgery (N = 888) |
Age at Index, mean (SD)* | 60.2 (14.4) | 60.9 (14.3) | 59.0 (14.5) |
18 - 30, % | 2.4 | 2.2 | 2.7 |
30 - 50, % | 18.9 | 17.8 | 21.0 |
50 - 65, % | 44.2 | 43.2 | 45.8 |
≥65, %* | 34.5 | 36.8 | 30.5 |
Female, % | 37.3 | 36.3 | 39.1 |
Health Insurance Plan |
|
|
|
Comprehensive | 18.3 | 18.5 | 17.9 |
HMO | 13.4 | 14.2 | 12.2 |
POS | 6.1 | 6.4 | 5.5 |
PPO | 54.2 | 53.5 | 55.5 |
Other plans | 8.0 | 7.4 | 8.9 |
Metastatic site at Index, % |
|
|
|
Lung | 14.3 | 15.2 | 12.8 |
Brain* | 12.4 | 14.8 | 8.2 |
Distant skin* | 18.3 | 12.7 | 27.7 |
Bone* | 7.2 | 8.5 | 5.0 |
Liver* | 6.7 | 8.0 | 4.5 |
Multiple sites* | 9.5 | 11.5 | 6.1 |
Length of follow-up, mean days (SD)* | 376.5 (426.7) | 275.9 (333.4) | 547.8 (506.3) |
Length of follow-up, median days* | 224 | 161 | 383.5 |